Phreesia, Inc.

NYSE:PHR

Medical - Healthcare Information Services

Healthcare
$12.26 +0.80%

+$0.08 today

Market cap
$760.99M
Beta
0.88
P/E (TTM)
62.6
EPS (TTM)
$0.15
52W Low $7.77High $32.76

Volume 0.86M

Average 1.97M

PHR Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Phreesia, Inc.NYSE: PHR

Gross Margin · Q1 FY2027 · quarter ended Apr 2026

Gross margin narrows to 59.2%

Gross margin was 59.2% in Q1 FY2027, down 8.0 pp from a year earlier. On a trailing-twelve-month basis it was 65.8%, down 2.2 pp year over year. Over 3 fiscal years it widened by 6.8 pp.

Context

  • Gross margin widened in 3 of the last 3 fiscal years.
  • FY2026 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterApr 2026
59.2%-9.0 pp QoQ
Last fiscal yearJan 2026
67.9%+0.1 pp YoY
LTMApr 2026
65.8%-2.2 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-8.0 pp——
1 year+0.1 pp——
3 years+6.8 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2026
67.9%
Year-over-year change
+0.1pp

Gross Margin vs competitors

How PHR compares with its peers on the latest reported figures

  • PHR's LTM Apr 2026 gross margin of 65.8% is the 5th highest of the 11 companies compared; the peer median is 64.8%.
  • Its year-over-year change of -2.2 pp is the 8th highest of 11, against a peer median of +0.3 pp.
  • Over three fiscal years its change of +6.8 pp compares with a peer median of +0.4 pp.
PHR Competitors Peer median
Gross Margin for PHR and competitors
Company Period LTM level YoY 3-year change
GDRXGoodRx Holdings, Inc.LTM Mar 202686.6% -7.3 pp+1.3 pp
NVCRNovoCure LimitedLTM Mar 202675.2% -2.0 pp-4.1 pp
ESTAEstablishment Labs Holdings Inc.LTM Sep 202670.2% +1.4 pp+3.4 pp
OMDAOmada HealthLTM Mar 202666.2% +4.6 pp+17.7 pp
PHRPhreesia, Inc.LTM Apr 202665.8% -2.2 pp+6.8 pp
TDOCTeladoc Health, Inc.LTM Mar 202665.6% -4.9 pp+0.4 pp
BLFSBioLife Solutions, Inc.LTM Mar 202663.9% -19.5 pp+3.0 pp
SDGRSchrödinger, Inc.LTM Sep 202658.5% +0.4 pp-0.1 pp
KMTSKestra Medical Technologies, Ltd.LTM Jan 202648.8% +14.6 pp—
NEOGNeogen CorporationLTM Aug 202647.4% +6.3 pp-2.4 pp
OMCLOmnicell, Inc.LTM Mar 202643.5% +0.3 pp-2.6 pp
Peer median (excluding PHR) 64.8%+0.3 pp+0.4 pp

Competitors are the stored peer set for PHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jan 2022
FY2023
Jan 2023
FY2024
Jan 2024
FY2025
Jan 2025
FY2026
Jan 2026
Revenue213.23M280.91M356.3M419.81M480.59M
Cost of Revenue81.39M109.27M124.01M134.93M154.12M
Gross Profit131.85M171.64M232.29M284.88M326.47M
Gross Margin61.8%61.1%65.2%67.9%67.9%
Research & Development52.27M91.24M112.35M117.36M121.48M
Selling, General & Admin175.1M231.65M226.93M197.73M180.15M
Operating Expenses248.66M348.2M368.77M342.98M333.08M
Depreciation & Amortization24.52M28.77M30.54M27.89M31.45M
EBITDA(92.3M)(145.48M)(102.95M)(25.58M)29.47M
EBITDA Margin-43.3%-51.8%-28.9%-6.1%6.1%
Operating Income(116.82M)(176.55M)(136.48M)(58.1M)(6.61M)
Operating Margin-54.8%-62.9%-38.3%-13.8%-1.4%
Interest Income79K2.48M4.07M2.68M2.17M
Interest Expense1.16M1.41M1.85M2.35M6.95M
Other Income / Expenses(1.16M)889K1.14M2.29M(2.33M)
Income Before Tax(117.98M)(175.66M)(135.34M)(55.81M)(8.94M)
Pre-Tax Margin-55.3%-62.5%-38.0%-13.3%-1.9%
Income Tax Expense182K483K1.54M2.72M(11.25M)
Net Income(118.16M)(176.15M)(136.89M)(58.53M)2.31M
Net Margin-55.4%-62.7%-38.4%-13.9%0.5%
EPS (Basic)(2.37)(3.36)(2.51)(1.02)0.04
EPS (Diluted)(2.37)(3.36)(2.51)(1.02)0.04
Weighted Avg Shares49.89M52.44M54.56M57.59M59.74M
Weighted Avg Shares (Diluted)49.89M52.44M54.56M57.59M61.49M

Phreesia, Inc.

NYSE:PHR

Intrinsic Alpha fair value

Locked

Current Price

$12.26

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.